George H. Goldsmith

948 total citations
35 papers, 723 citations indexed

About

George H. Goldsmith is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, George H. Goldsmith has authored 35 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in George H. Goldsmith's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Platelet Disorders and Treatments (6 papers). George H. Goldsmith is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Platelet Disorders and Treatments (6 papers). George H. Goldsmith collaborates with scholars based in United States. George H. Goldsmith's co-authors include Hiromi Saito, Philip J. Spagnuolo, Bruce Furie, Birgitte Andersen, Hidehiko Saito, M Borowski, Oscar D. Ratnoff, Nicholas P. Ziats, Abel L. Robertson and Masaaki Moroi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

George H. Goldsmith

35 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George H. Goldsmith United States 15 271 194 137 97 82 35 723
N. Stathakis Greece 18 178 0.7× 84 0.4× 114 0.8× 121 1.2× 38 0.5× 38 656
J. D. Parkin Australia 19 109 0.4× 84 0.4× 106 0.8× 167 1.7× 50 0.6× 43 747
Y Carcassonne France 17 399 1.5× 189 1.0× 133 1.0× 179 1.8× 134 1.6× 115 1.1k
Susumu Yasuoka Japan 20 198 0.7× 137 0.7× 304 2.2× 195 2.0× 220 2.7× 55 1.1k
Helena Alves Portugal 17 192 0.7× 123 0.6× 86 0.6× 125 1.3× 217 2.6× 60 811
D. Kyriakou Greece 21 368 1.4× 133 0.7× 100 0.7× 190 2.0× 166 2.0× 44 872
R. L. Priore United States 17 217 0.8× 55 0.3× 269 2.0× 232 2.4× 144 1.8× 30 1.1k
John B. Miller United States 15 200 0.7× 96 0.5× 78 0.6× 195 2.0× 234 2.9× 40 961
Neal S. Young United States 11 586 2.2× 325 1.7× 35 0.3× 122 1.3× 193 2.4× 30 1.1k
D Ménaché United States 20 621 2.3× 102 0.5× 328 2.4× 230 2.4× 52 0.6× 65 1.3k

Countries citing papers authored by George H. Goldsmith

Since Specialization
Citations

This map shows the geographic impact of George H. Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George H. Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George H. Goldsmith more than expected).

Fields of papers citing papers by George H. Goldsmith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George H. Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George H. Goldsmith. The network helps show where George H. Goldsmith may publish in the future.

Co-authorship network of co-authors of George H. Goldsmith

This figure shows the co-authorship network connecting the top 25 collaborators of George H. Goldsmith. A scholar is included among the top collaborators of George H. Goldsmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George H. Goldsmith. George H. Goldsmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laber, Damian A., et al.. (2006). A Phase II Study of Higher Dose Docetaxel in Androgen-Independent Prostate Cancer. American Journal of Clinical Oncology. 29(4). 389–394. 4 indexed citations
2.
Fleming, Donald R., et al.. (2003). Cefepime Versus Ticarcillin and Clavulanate Potassium and Aztreonam for Febrile Neutropenia Therapy in High-Dose Chemotherapy Patients. American Journal of Clinical Oncology. 26(3). 285–288. 7 indexed citations
3.
Fleming, Donald R., et al.. (2003). . American Journal of Clinical Oncology. 26(3). 285–288. 1 indexed citations
4.
Goldsmith, George H.. (2001). Hemostatic Changes in Patients with Malignancy. International Journal of Hematology. 73(2). 151–156. 4 indexed citations
5.
Fleming, Donald R., et al.. (2000). Mobilization of Peripheral Blood Stem Cells in High-Risk Breast Cancer Patients Using G-CSF After Standard Dose Docetaxel. Journal of Hematotherapy & Stem Cell Research. 9(6). 855–860. 6 indexed citations
6.
Fleming, Donald R., et al.. (2000). Phase I Study of Paclitaxel and Day 1/Day 8 Gemcitabine in Patients With Solid Malignancies. American Journal of Clinical Oncology. 23(4). 349–352. 15 indexed citations
7.
Djulbegović, Benjamin, Thomas P. Loughran, Carlton A. Hornung, et al.. (1999). The quality of medical evidence in hematology-oncology. The American Journal of Medicine. 106(2). 198–205. 39 indexed citations
8.
Pierangeli, Silvia S., George H. Goldsmith, D. Ware Branch, & E. Nigel Harris. (1997). Antiphospholipid antibody: functional specificity for inhibition of prothrombin activation by the prothrombinase complex. British Journal of Haematology. 97(4). 768–774. 9 indexed citations
9.
Djulbegović, Benjamin, et al.. (1996). Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B. American Journal of Hematology. 51(2). 168–170. 14 indexed citations
10.
11.
Goldsmith, George H., Silvia S. Pierangeli, D. Ware Branch, A E Gharavi, & E. Nigel Harris. (1994). Inhibition of prothrombin activation by antiphospholipid antibodies and β2‐glycoprotein 1. British Journal of Haematology. 87(3). 548–554. 31 indexed citations
12.
Pierangeli, S S, et al.. (1994). Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndrome. Infection and Immunity. 62(9). 4081–4084. 21 indexed citations
13.
Silverman, Paula, et al.. (1990). Effect of tumor necrosis factor on the human fibrinolytic system.. Journal of Clinical Oncology. 8(3). 468–475. 12 indexed citations
14.
Silverman, Paula, et al.. (1990). Effect of Tumor Necrosis Factor on the Human Fibrinolytic System. Journal of Clinical Oncology. 8(9). 1602–1602. 6 indexed citations
15.
Kazura, J W, Jay D. Wenger, Robert A. Salata, Andrei Z. Budzynski, & George H. Goldsmith. (1989). Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.. Journal of Clinical Investigation. 83(6). 1916–1924. 32 indexed citations
16.
Hricik, Donald E. & George H. Goldsmith. (1988). Uric acid nephrolithiasis and acute renal failure secondary to streptozotocin nephrotoxicity. The American Journal of Medicine. 84(1). 153–156. 8 indexed citations
17.
Goldsmith, George H., et al.. (1982). Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors.. Journal of Clinical Investigation. 69(6). 1253–1260. 42 indexed citations
18.
Goldsmith, George H., Nicholas P. Ziats, & Abel L. Robertson. (1981). Studies on plasminogen activator and other proteases in subcultured human vascular cells. Experimental and Molecular Pathology. 35(2). 257–264. 23 indexed citations
19.
Goldsmith, George H., Hidehiko Saito, & Walter Muir. (1981). Labile anticoagulant in a patient with lymphoma. American Journal of Hematology. 10(3). 305–311. 3 indexed citations
20.
Levin, Jack, Thomas Butler, George B. Naff, et al.. (1977). Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection. The American Journal of Medicine. 63(6). 933–938. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Stathakis Breakdown of academic impact, for papers by J. D. Parkin Breakdown of academic impact, for papers by Y Carcassonne Breakdown of academic impact, for papers by Susumu Yasuoka Breakdown of academic impact, for papers by Helena Alves Breakdown of academic impact, for papers by D. Kyriakou Breakdown of academic impact, for papers by R. L. Priore Breakdown of academic impact, for papers by John B. Miller Breakdown of academic impact, for papers by Neal S. Young Breakdown of academic impact, for papers by D Ménaché
Rankless by CCL
2026